Clinical Trials Logo

Hyperopia clinical trials

View clinical trials related to Hyperopia.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06371079 Recruiting - Myopia Clinical Trials

Safety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDs

Start date: March 1, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to test whether surgeries for lenses designed to be implanted in the eye to correct refractive error can be done without the need for using viscoelastic substances that are used routinely nowadays to make it easier to introduce them inside the human eye and protect the inside of the eye during the operation. The main question it aims to answer is that is it safe to do the surgery without using them? to answer this question researchers will access recorded data of patients that underwent refractive surgeries in a private clinic since 2017 and compare them as two groups: those who underwent the traditional procedures and those who had it without the use of dispersive viscoelastics in regard to their vision before and after surgery, their ocular pressure and biomicroscopic analysis of the inside of their corneas before and after surgery.

NCT ID: NCT05477875 Recruiting - Myopia Clinical Trials

Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control

Start date: February 1, 2024
Phase: Phase 2
Study type: Interventional

Photorefractive Keratectomy (PRK) is a commonly performed corneal refractive surgery but has significant post-operative pain. Pain medications after PRK are typically opioid-acetaminophen combinations. Alternatives to opioid medication are worth consideration. Patients will receive PRK in each eye sequentially, using the cannabinoid or codeine/acetaminophen for one eye and the other treatment for the fellow eye two weeks later.

NCT ID: NCT05264623 Recruiting - Hyperopia Clinical Trials

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

This will be a multicenter, prospective, open label, non-randomized, single arm 12 month study, evaluating the safety and effectiveness of the TECHNOLAS TENEO 317 Model 2 (Software version "1.28 US") excimer laser when used in LASIK surgery to treat hyperopia with or without hyperopic astigmatism. Both eyes of a subject may be enrolled so long as both eyes meet all inclusion/exclusion requirements. Analysis of the primary effectiveness endpoint will be completed at refractive stability.

NCT ID: NCT04632784 Recruiting - Myopia Clinical Trials

Clinical Trial With Artiflex Presbyopic

Start date: November 12, 2021
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to evaluate the effectiveness and safety of the multifocal Artiflex Presbyopic intraocular lens.

NCT ID: NCT04283331 Recruiting - Myopia Clinical Trials

Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK)

Start date: June 1, 2020
Phase: Phase 4
Study type: Interventional

Compared to laser-assisted in situ keratomileusis (LASIK), Photorefractive Keratectomy (PRK) is associated with more discomfort and requires more downtime. However, it is oftentimes considered the preferred method of refractive surgery for patients with dry eye syndrome, high refractive errors, thin corneas, or those with more active lifestyles who may be more prone to dislodging their LASIK flaps. We hypothesize that the use of bandage contact lenses soaked in proparacaine will decrease pain levels compared to solely the use of bandage contact lenses after PRK.

NCT ID: NCT02576483 Recruiting - Astigmatism Clinical Trials

An Evaluation of LASIK, SMILE and PRK Surgery in Physicians

Start date: July 2015
Phase:
Study type: Observational

The principle investigator is evaluating self-reported quality of vision and quality of life in physicians undergoing LASIK, SMILE and PRK surgery.

NCT ID: NCT02316041 Recruiting - Hyperopia Clinical Trials

Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction

Start date: January 2014
Phase: N/A
Study type: Interventional

This is a feasibility and clinical evaluation study of the VisuMax femtosecond laser for refractive correction of hyperopia using the small incision lenticule extraction (ReLEx smile) method. In ReLEx® the VisuMax femtosecond laser creates two interfaces that define a refractive lenticule of stromal tissue. In ReLEx® FLEx, the upper interface is converted into a LASIK flap by the creation of a sidecut. The LASIK flap is lifted and the lenticule can be removed to correct the refractive error by tissue subtraction. In ReLEx® smile, the lenticule is dissected and removed through a small 2-3mm incision without the need to create a whole flap. The aims are i) to optimize the VisuMax settings for lenticule separation ii) to optimize the lenticule geometry iii) to assess the safety, efficacy and stability of the treatment

NCT ID: NCT02279446 Recruiting - Myopia Clinical Trials

Development of a Validated Chart for Intermediate Vision Assessment

Start date: October 2014
Phase: N/A
Study type: Observational

Development of a validated computer-based instrument (software program) for the assessment of intermediate visual acuity.

NCT ID: NCT02148016 Recruiting - Myopia Clinical Trials

Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation

Start date: December 2012
Phase: Phase 1/Phase 2
Study type: Interventional

Corneal disease is a leading cause of blindness in the world. A shortage of corneal donor tissue has prevented many patients from regaining vision. Additionally, refractive error such as myopia is a major cause of impaired visual function worldwide. Although refractive error is correctable by procedures that modify the refractive power of the cornea, these procedures often weaken corneal integrity and have risk of complications. This study aims to evaluate the safety and efficacy of corneal surface epithelium repair and regeneration in the treatment of corneal surface diseases and refractive error using autologous limbal stem cell transplantation.

NCT ID: NCT02071576 Recruiting - Myopia Clinical Trials

A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIK

Start date: February 2014
Phase: Phase 4
Study type: Interventional

This clinical study has been planned to evaluate the safety and effectiveness of a common treatment algorithms (Proscan) using 500 Hz laser repetition rate.